Establishment Labs Holdings Inc logo

ESTA

Establishment Labs Holdings Inc

$64.65

Earnings Summary

Revenue
$38.45Mn
Net Profits
$-5.93Mn
Net Profit Margins
-15.43%

Highlights

Revenue:

Establishment Labs Holdings Inc’s revenue jumped 26.75% since last year same period to $38.45Mn in the Q1 2022. On a quarterly growth basis, Establishment Labs Holdings Inc has generated 8.89% jump in its revenue since last 3-months.

Net Profits:

Establishment Labs Holdings Inc’s net profit jumped 14.61% since last year same period to $-5.93Mn in the Q1 2022. On a quarterly growth basis, Establishment Labs Holdings Inc has generated 58.19% jump in its net profits since last 3-months.

Net Profit Margins:

Establishment Labs Holdings Inc’s net profit margin jumped 32.63% since last year same period to -15.43% in the Q1 2022. On a quarterly growth basis, Establishment Labs Holdings Inc has generated 61.6% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Establishment Labs Holdings Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.4
EPS Estimate Current Year
-0.4

Highlights

EPS Estimate Current Quarter:

Establishment Labs Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at -0.4 - a -5.26% fall from last quarter’s estimates.

EPS Estimate Current Year:

Establishment Labs Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.4.

Key Ratios

Key ratios of the Establishment Labs Holdings Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.24
Return on Assets (ROA)
-0.12
Return on Equity (ROE)
-1.7
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Establishment Labs Holdings Inc’s earning per share (EPS) jumped 17.24% since last year same period to -0.24 in the Q1 2022. This indicates that the Establishment Labs Holdings Inc has generated 17.24% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Establishment Labs Holdings Inc’s return on assets (ROA) stands at -0.12.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Establishment Labs Holdings Inc’s return on equity (ROE) stands at -1.7.

Dividend Per Share (DPS):

Establishment Labs Holdings Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
-0.38
-0.24
36.84%

Company Information

Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in more than 80 countries through exclusive distributors or the Company's direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA and initiated the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs' product and technologies portfolio includes the Divina® 3D Simulation System and other products and services.

Organisation
Establishment Labs Holdings Inc
Headquarters
Coyol Free Zone, Alajuela, Costa Rica
Employees
521
Industry
Health Technology
CEO
Juan Jose Chacon Quiros